Show simple item record

dc.contributor.authorKaria, A.
dc.contributor.authorKravitz, L.
dc.contributor.authorShah, C.
dc.date.accessioned2010-06-14T13:58:48Z
dc.date.available2010-06-14T13:58:48Z
dc.date.issued2010-04
dc.identifier.citationKaria , A , Kravitz , L & Shah , C 2010 , ' Schizophrenia: helping patients adhere to long-term management plans ' , Chemist and Druggist , vol. 1523 , pp. 17-21 .
dc.identifier.issn0009-3033
dc.identifier.otherPURE: 185284
dc.identifier.otherPURE UUID: ab96d307-8e1d-4c1e-9996-39c5e8c70823
dc.identifier.otherdspace: 2299/4572
dc.identifier.urihttp://hdl.handle.net/2299/4572
dc.descriptionOriginal article can be found at: http://www.chemistanddruggist.co.uk/
dc.description.abstractSchizophrenia affects around one in every 100 people during their lifetime. First symptoms are typically experienced between the ages of 15 and 35, and the disease affects men and women equally. Incidence is higher in cities, and in migrant and ethnic minority groups. Schizophrenia is a psychiatric disorder that alters an individual’s perception, thoughts, affect and behaviour. It can often be distressing for individuals and their family, and can influence their personal, social and occupational lives. Early and accurate diagnosis, intervention and the selection of effective treatment(s) are paramount in improving quality of life.en
dc.language.isoeng
dc.relation.ispartofChemist and Druggist
dc.rightsOpen
dc.titleSchizophrenia: helping patients adhere to long-term management plansen
dc.contributor.institutionDepartment of Pharmacy
dc.description.statusPeer reviewed
dcterms.dateAccepted2010-04
rioxxterms.typeJournal Article/Review
herts.preservation.rarelyaccessedtrue
herts.rights.accesstypeOpen


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record